Bariatric Surgery

BOSTON — September 15, 2026 Syntis Bio, Inc. announced results from the 28-day multiple-ascending-dose (MAD) portion of its Phase...

GOTHENBURG, Sweden — September 8, 2026 Epicyt Pharma AB reported positive topline results from its Phase 1/2a first-in-human study...

CAESAREA, Israel, July 28, 2026 Nitinotes Ltd. has completed the first study procedures at Orlando Health in its pivotal...

SANTA CLARA, Calif., United States – May 5, 2026 Johnson & Johnson has announced pivotal clinical study results for...